Synthesis and pharmacological evaluation of a new class of peroxisome proliferator-activated receptor modulators
摘要:
A series of 5-substituted 2-benzoylaminobenzoic acids has been synthesized and assayed for PPARalpha/gamma activity. Both dual activators and selective PPARgamma agonists have been identified. This class of compounds was shown to activate the PPARgamma receptor through interaction with a novel binding site. (C) 2002 Elsevier Science Ltd. All rights reserved.
A series of 5-substituted 2-benzoylaminobenzoic acids has been synthesized and assayed for PPARalpha/gamma activity. Both dual activators and selective PPARgamma agonists have been identified. This class of compounds was shown to activate the PPARgamma receptor through interaction with a novel binding site. (C) 2002 Elsevier Science Ltd. All rights reserved.
Compounds
申请人:——
公开号:US20030073862A1
公开(公告)日:2003-04-17
The present invention relates to 2-(benzoylamino)benzoic acid derivatives of the formula I
1
wherein the variants Ar, X and R are as described in the specification. The said compounds modulate the activity of peroxisome proliferator-activated receptors (PPAR) &agr; and/or &ggr;, and are predicted to be useful in the treatment of metabolic diseases, e.g. type II diabetes.